東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The Use of Artificial Intelligence f...

Kim, Era.

FindBook

Google Book

Amazon

博客來

The Use of Artificial Intelligence for Precision Medicine in Metabolic Syndrome.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The Use of Artificial Intelligence for Precision Medicine in Metabolic Syndrome./
作者:	Kim, Era.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
面頁冊數:	139 p.
附註:	Source: Dissertation Abstracts International, Volume: 80-08(E), Section: B.
Contained By:	Dissertation Abstracts International80-08B(E).
標題:	Medicine. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13806194
ISBN:	9781392015155

The Use of Artificial Intelligence for Precision Medicine in Metabolic Syndrome.
Kim, Era.

The Use of Artificial Intelligence for Precision Medicine in Metabolic Syndrome. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 139 p.

Source: Dissertation Abstracts International, Volume: 80-08(E), Section: B.

Thesis (Ph.D.)--University of Minnesota, 2019.

Type 2 Diabetes Mellitus (T2DM) is a chronic, progressive metabolic disorder, associated with an increased risk of developing micro- and macrovascular complications. Because of its interactive and heterogeneous nature, the management of T2DM is very complex. For the successful management of T2DM, the use of individualized and evidence-based clinical guidelines is necessary.

ISBN: 9781392015155Subjects--Topical Terms:

641104
Medicine.

The Use of Artificial Intelligence for Precision Medicine in Metabolic Syndrome.
LDR:03394nmm a2200433 4500 001 2204480
005 20190716100707.5
008 201008s2019 ||||||||||||||||| ||eng d
020 $a 9781392015155
035 $a (MiAaPQ)AAI13806194
035 $a (MiAaPQ)umn:20061
035 $a AAI13806194
040 $a MiAaPQ $c MiAaPQ
100 1 $a Kim, Era. $3 3431349
245 1 4 $a The Use of Artificial Intelligence for Precision Medicine in Metabolic Syndrome.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 139 p.
500 $a Source: Dissertation Abstracts International, Volume: 80-08(E), Section: B.
500 $a Adviser: Gyorgy Simon.
502 $a Thesis (Ph.D.)--University of Minnesota, 2019.
520 $a Type 2 Diabetes Mellitus (T2DM) is a chronic, progressive metabolic disorder, associated with an increased risk of developing micro- and macrovascular complications. Because of its interactive and heterogeneous nature, the management of T2DM is very complex. For the successful management of T2DM, the use of individualized and evidence-based clinical guidelines is necessary.
520 $a Randomized controlled trials (RCTs) are considered the gold standard for clinical research. However, the results from RCTs can be inconclusive, leaving many aspects of T2DM management unaddressed. Therefore, there exists a huge gap between the optimal individualized and the current patient care.
520 $a To fill some of the gap, there are opportunities of artificial intelligence (AI) in medicine, because big data and advanced machine learning (ML) techniques offer a new way to generate evidence that enhances clinical practice guidelines with more personalized recommendations.
520 $a My overarching goal is to build clinically useful and transferable machine learning models on big data that can influence individual T2DM patient care towards the implementation of precision medicine. Under this goal, I had three specific aims, which I successfully achieved.
520 $a • Specific aim 1: To develop a semi-supervised divisive hierarchical clustering algorithm for a subpopulation-based T2DM risk score.
520 $a • Specific aim 2: To develop a Multi-Task Learning (MTL)-based methodology to reveal outcome-specific effects by separating the overall deterioration of metabolic health from progression to individual complications.
520 $a • Specific aim 3: To demonstrate that even a complex ML model built on nationally representative data can be transferred to two local health systems without significant loss of predictive performance.
520 $a In the management of T2DM, which is complex, the availability of reliable clinical evidence is critical for clinicians to make the right decision and produce high-quality care in healthcare delivery. Against the backdrop of RCTs, AI in medicine can reduce the gap between optimal individualized and current T2DM patient care. And building clinically useful and transferable ML models will especially facilitate the implementation of precision medicine in T2DM.
590 $a School code: 0130.
650 4 $a Medicine. $3 641104
650 4 $a Computer science. $3 523869
650 4 $a Statistics. $3 517247
650 4 $a Endocrinology. $3 610914
650 4 $a Physiology. $3 518431
650 4 $a Public health. $3 534748
690 $a 0564
690 $a 0984
690 $a 0463
690 $a 0409
690 $a 0719
690 $a 0573
710 2 $a University of Minnesota. $b Health Informatics. $3 1266007
773 0 $t Dissertation Abstracts International $g 80-08B(E).
790 $a 0130
791 $a Ph.D.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13806194